ARCHIVES

Agencies Plan Better Reporting Of Adverse Events In Trials.

This article is from The Cancer Letter archive.

Vol. 26 No. 05 | February 4, 2000

Download PDF Visit The Full Archive

Related Articles

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Foundation offers funds for mesothelioma research.

July 9, 2004

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002